O5 CRISPR/Cas9-derived activation systems as new tools for induction of latent human immunodeficiency virus (HIV)
JuliaK Bialek,
Maike Voges,
Gabor A. Dunay,
Carola Schäfer,
Michael Spohn,
Joachim Hauber,
Ulrike C. Lange
Affiliations
JuliaK Bialek
Heinrich Pette Institute – Leibniz Institute for Experimental Virology, Hamburg, Germany
Maike Voges
Heinrich Pette Institute – Leibniz Institute for Experimental Virology, Hamburg, Germany
Gabor A. Dunay
Heinrich Pette Institute – Leibniz Institute for Experimental Virology, Hamburg, Germany; German Center for Infection Research (DZIF), partner site Hamburg, Germany.
Carola Schäfer
Heinrich Pette Institute – Leibniz Institute for Experimental Virology, Hamburg, Germany; German Center for Infection Research (DZIF), partner site Hamburg, Germany.
Michael Spohn
Heinrich Pette Institute – Leibniz Institute for Experimental Virology, Hamburg, Germany
Joachim Hauber
Heinrich Pette Institute – Leibniz Institute for Experimental Virology, Hamburg, Germany; German Center for Infection Research (DZIF), partner site Hamburg, Germany.
Ulrike C. Lange
Heinrich Pette Institute – Leibniz Institute for Experimental Virology, Hamburg, Germany; Department of Anesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), partner site Hamburg, Germany.
